Jorge Santana

2.3k total citations
16 papers, 950 citations indexed

About

Jorge Santana is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Jorge Santana has authored 16 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 12 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Jorge Santana's work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (7 papers). Jorge Santana is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (7 papers). Jorge Santana collaborates with scholars based in Puerto Rico, United States and Mexico. Jorge Santana's co-authors include Daniel R. Kuritzkes, Joseph J. Eron, Marc Rubin, Joseph G. Jemsek, Rodger D. MacArthur, Sharon L. Benoit, Joseph Quinn, Edna E. Aquino, Iraida E. Robledo and Guillermo J. Vázquez and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and The Journal of Infectious Diseases.

In The Last Decade

Jorge Santana

15 papers receiving 922 citations

Peers

Countries citing papers authored by Jorge Santana

Since Specialization

Citations

This map shows the geographic impact of Jorge Santana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Santana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Santana more than expected).

Fields of papers citing papers by Jorge Santana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Santana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Santana. The network helps show where Jorge Santana may publish in the future.

Co-authorship network of co-authors of Jorge Santana

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Santana. A scholar is included among the top collaborators of Jorge Santana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Santana. Jorge Santana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	O322: Sofosbuvir and ribavirin therapy for the treatment of HIV/HCV co-infected patients with HCV GT1-4 infection: the PHOTON-1 and -2 Trials 2015 ·Journal of the International AIDS Society ·Jorge Santana, Juergen Rockstroh, Massimo Puoti, M. Rodríguez‐Torres, Douglas T. Dieterich, Anuj Gaggar, Liyun Ni, Benedetta Massetto, Evguenia S. Svarovskaia, Diana M. Brainard, Mani Subramanian, John G. McHutchison, Susanna Naggie, Chloe Orkin, Jean‐Michel Molina, Mark Sulkowski	0
2	HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors 2015 ·Annals of Internal Medicine ·Karen T. Tashima, Laura Smeaton, Carl J. Fichtenbaum, Adriana Andrade, Joseph J. Eron, Rajesh T. Gandhi, Victoria A. Johnson, Karin L. Klingman, Justin Ritz, Sally Hodder, Jorge Santana, Timothy Wilkin, Richard Haubrich, (unknown)	11
3	Changes in Fat Mitochondrial DNA and Function in Subjects Randomized to Abacavir-Lamivudine or Tenofovir DF–Emtricitabine With Atazanavir-Ritonavir or Efavirenz: AIDS Clinical Trials Group Study A5224s, Substudy of A5202 2012 ·The Journal of Infectious Diseases ·Grace A. McComsey, Eric S. Daar, MaryAnn O’Riordan, Ann C. Collier, Lisa A. Kosmiski, Jorge Santana, Carl J. Fichtenbaum, (unknown), Paul E. Sax, Daniel Libutti, Mariana Gerschenson	45
4	Incidence of Non-AIDS-Defining Cancer in Antiretroviral Treatment-Naïve Subjects after Antiretroviral Treatment Initiation: An ACTG Longitudinal Linked Randomized Trials Analysis 2011 ·Oncology ·Supriya Krishnan, Jeffrey T. Schouten, Denise L. Jacobson, Constance A. Benson, Ann C. Collier, Susan L. Koletar, Jorge Santana, Fred R. Sattler, Ronald T. Mitsuyasu, (unknown)	32
5	Detection of KPC in Acinetobacter spp. in Puerto Rico 2009 ·Antimicrobial Agents and Chemotherapy ·Iraida E. Robledo, Edna E. Aquino, (unknown), Jorge Santana, (unknown), (unknown), Guillermo J. Vázquez	167
6	Clinical experience with posaconazole in patients with invasive mucormycosis: a case series. 2008 ·PubMed ·(unknown), Jorge Bertrán‐Pasarell, (unknown), (unknown), Jorge Santana, (unknown), (unknown)	6
7	Plasma HIV‐1 RNA Dynamics in Antiretroviral‐Naive Subjects Receiving either Triple‐Nucleoside or Efavirenz‐Containing Regimens: ACTG A5166s 2007 ·The Journal of Infectious Diseases ·Daniel R. Kuritzkes, Heather J. Ribaudo, Kathleen Squires, Susan L. Koletar, Jorge Santana, Sharon A. Riddler, Richard C. Reichman, Cecilia M. Shikuma, William A. Meyer, Karin L. Klingman, Roy M. Gulick, (unknown)	34
8	Amdoxovir versus Placebo with Enfuvirtide plus Optimized Background Therapy for HIV-1-Infected Subjects Failing Current Therapy (Aactg A5118) 2006 ·Antiviral Therapy ·Barbara Gripshover, (unknown), Jorge Santana, John G. Gerber, Thomas Campbell, Evelyn Hogg, Bernadette Jarocki, Scott M. Hammer, Daniel R. Kuritzkes	17
9	Lack of Evidence for In Vivo Transformation of Zidovudine Triphosphate to Stavudine Triphosphate in Human Immunodeficiency Virus-Infected Patients 2006 ·Antimicrobial Agents and Chemotherapy ·(unknown), (unknown), (unknown), (unknown), Jorge Santana, (unknown), Osvaldo Rosario, José F. Rodrígúez	4
10	Persistent Antiretroviral Activity of Nucleoside Analogues After Prolonged Zidovudine and Lamivudine Therapy as Demonstrated by Rapid Loss of Activity After Discontinuation 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Joseph J. Eron, John Bartlett, Jorge Santana, (unknown), Judy Johnson, (unknown), Daniel R. Kuritzkes, M H St Clair, Victoria A. Johnson	30
11	Clinical challenges and controversies in the management of HIV/ HCV-coinfected individuals. 2004 ·PubMed ·Jorge Santana, José R Rodríguez-Medina, José F. Rodríguez‐Orengo	3
12	A Randomized Trial of Nelfinavir and Abacavir in Combination with Efavirenz and Adefovir Dipivoxil in HIV-1-Infected Persons with Virological Failure Receiving Indinavir 2003 ·Antiviral Therapy ·Scott M. Hammer, Roland L. Bassett, Kathleen Squires, Margaret A. Fischl, Lisa M. Demeter, Judith S. Currier, John W. Mellors, Gene D. Morse, Joseph J. Eron, Jorge Santana, Victor DeGruttola, (unknown)	11
13	A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I) 2000 ·AIDS ·Kathleen Squires, Roy M. Gulick, Pablo Tebas, Jorge Santana, Victor E. Mulanovich, Rebecca A. Clark, Bienvenido G. Yangco, Steven I. Marlowe, David J. Wright, Calvin Cohen, Timothy P. Cooley, (unknown), (unknown), (unknown), (unknown), M. L. Stevens	74
14	Simultaneous Quantitation of Intracellular Zidovudine and Lamivudine Triphosphates in Human Immunodeficiency Virus-Infected Individuals 2000 ·Antimicrobial Agents and Chemotherapy ·José F. Rodrígúez, Jorge L. Rodriguez, Jorge Santana, (unknown), Osvaldo Rosario	54
15	Determination of Zidovudine Triphosphate Intracellular Concentrations in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus-Infected Individuals by Tandem Mass Spectrometry 1999 ·Antimicrobial Agents and Chemotherapy ·(unknown), Osvaldo Rosario, Jorge Santana, (unknown), Jean‐Pierre Sommadossi, José F. Rodrígúez	44
16	Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter 1995 ·New England Journal of Medicine ·Joseph J. Eron, Sharon L. Benoit, Joseph G. Jemsek, Rodger D. MacArthur, Jorge Santana, Joseph Quinn, Daniel R. Kuritzkes, (unknown), Marc Rubin	418

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact